Lansoprazole and Esomeprazole in Symptomatic GERD

This publication has 15 references indexed in Scilit:

• Esomeprazole (40 Mg) Compared With Lansoprazole (30 Mg) in The Treatment of Erosive Esophagitis
  American Journal of Gastroenterology, 2002
• Evidence for Therapeutic Equivalence of Lansoprazole 30mg and Esomeprazole 40mg in the Treatment of Erosive Oesophagitis
  Clinical Drug Investigation, 2002
• Comparing lansoprazole and omeprazole in onset of heartburn relief: results of a randomized, controlled trial in erosive esophagitis patients
  American Journal of Gastroenterology, 2001
• Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials
  Clinical Therapeutics, 2001
• The Impact of Nocturnal Symptoms Associated With Gastroesophageal Reflux Disease on Health-Related Quality of Life
  Archives of internal medicine (1960), 2001
• Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: A double-blind, randomized clinical trial
  American Journal of Gastroenterology, 2000
• Esomeprazole
  Drugs, 2000
• Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis
  Alimentary Pharmacology & Therapeutics, 1996
• A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis
  Alimentary Pharmacology & Therapeutics, 1995
• Omepmazole or high‐dose ranitidine in the treatment of patients with reflux oesophagitis not responding to ‘standard doses’of H₂‐receptor antagonists
  Alimentary Pharmacology & Therapeutics, 1990